Media & Resources
Engage with the leading edge of biopharmaceuticals

Announcements

Bexion Pharmaceuticals welcomes three new members in the quest to develop cancer drugs.

Mr. Kyle Buller, former intern in 2011 and 2012, returns to support Bexion’s analytical team as he prepares for his last semester at Saint Louis University.

Mr. Lahiru Wimalasena, on summer break from Ohio State University, is interning with Bexion’s cell research team.

Mr. Will Geisen, Centre College graduate and former intern in 2010 and 2011, returns to Bexion as a full time Research Analyst.

Kyle Buller, Lahiru Wimalasena, Will Geisen
Kyle Buller (Left), Lahiru Wimalasena (Middle), Will Geisen (Right)

Congratulations to 2011 Summer Interns


Congratulations to Bexion’s summer interns, Mr. Will Geisen and Mr. Kyle Buller. Their work during their summer program greatly supported Bexion’s mission to develop cures for cancer. Mr. Geisen is starting a Master’s program at the University of Kentucky in Medical Sciences. Mr. Buller is entering his senior year at St. Louis University majoring in Biochemistry.

Will Geisen
Will Geisen
Kyle Buller
Kyle Buller